Alembic Pharma is attractively placed to deliver sustainable growth over the long haul, given its strong US business, focus on domestic speciality segment and commitment towards developing a long-term product pipeline through proactive investments in research and business.Investors with a three- to five-year time horizon can consider buying the stock. The stock is down 12 per cent from its Septemb...